505 related articles for article (PubMed ID: 17896140)
1. Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) is an independent prognostic indicator of worse outcome in gastric cancer patients.
Lieto E; Ferraraccio F; Orditura M; Castellano P; Mura AL; Pinto M; Zamboli A; De Vita F; Galizia G
Ann Surg Oncol; 2008 Jan; 15(1):69-79. PubMed ID: 17896140
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of epidermal growth factor receptor expression in colon cancer patients undergoing curative surgery.
Galizia G; Lieto E; Ferraraccio F; De Vita F; Castellano P; Orditura M; Imperatore V; La Mura A; La Manna G; Pinto M; Catalano G; Pignatelli C; Ciardiello F
Ann Surg Oncol; 2006 Jun; 13(6):823-35. PubMed ID: 16614884
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of vascular endothelial growth factor in squamous cell carcinomas of the tonsil in relation to human papillomavirus status and epidermal growth factor receptor.
Fei J; Hong A; Dobbins TA; Jones D; Lee CS; Loo C; Al-Ghamdi M; Harnett GB; Clark J; O'Brien CJ; Rose B
Ann Surg Oncol; 2009 Oct; 16(10):2908-17. PubMed ID: 19603236
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiles of epidermal growth factor receptor, vascular endothelial growth factor and hypoxia-inducible factor-1 with special reference to local responsiveness to neoadjuvant chemoradiotherapy and disease recurrence after rectal cancer surgery.
Toiyama Y; Inoue Y; Saigusa S; Okugawa Y; Yokoe T; Tanaka K; Miki C; Kusunoki M
Clin Oncol (R Coll Radiol); 2010 May; 22(4):272-80. PubMed ID: 20117921
[TBL] [Abstract][Full Text] [Related]
5. Biological markers and prognosis in recurrent oral cancer after salvage surgery.
Agra IM; Carvalho AL; Pinto CA; Martins EP; Filho JG; Soares FA; Kowalski LP
Arch Otolaryngol Head Neck Surg; 2008 Jul; 134(7):743-9. PubMed ID: 18645125
[TBL] [Abstract][Full Text] [Related]
6. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer.
Seto T; Higashiyama M; Funai H; Imamura F; Uematsu K; Seki N; Eguchi K; Yamanaka T; Ichinose Y
Lung Cancer; 2006 Jul; 53(1):91-6. PubMed ID: 16697074
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor C (VEGF-C) expression in pT2 gastric cancer.
Tsutsumi S; Kuwano H; Shimura T; Morinaga N; Mochiki E; Asao T
Hepatogastroenterology; 2005; 52(62):629-32. PubMed ID: 15816493
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer.
Carrillo de Santa Pau E; Arias FC; Caso Peláez E; Muñoz Molina GM; Sánchez Hernández I; Muguruza Trueba I; Moreno Balsalobre R; Sacristán López S; Gómez Pinillos A; del Val Toledo Lobo M
Cancer; 2009 Apr; 115(8):1701-12. PubMed ID: 19197998
[TBL] [Abstract][Full Text] [Related]
10. [Expression of transcription factor SP1, vascular endothelial growth factor and CD34 in serosa-infiltrating gastric cancer and their relationship with biological behavior and prognosis].
Wei YZ; Li CF; Xue YW
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Mar; 12(2):145-9. PubMed ID: 19296249
[TBL] [Abstract][Full Text] [Related]
11. Postoperative autovaccinotherapy for patients with gastric cancer and expression of some proteins in tumor tissue.
Bazas VM; Lukyanova NY; Lisovenko GS; Rozumiy DO; Potebnya GP
Exp Oncol; 2009 Sep; 31(3):182-4. PubMed ID: 19783961
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor, CD68, and epidermal growth factor receptor expression and survival in patients with Stage II and Stage III colon carcinoma: a role for the host response in prognosis.
Khorana AA; Ryan CK; Cox C; Eberly S; Sahasrabudhe DM
Cancer; 2003 Feb; 97(4):960-8. PubMed ID: 12569594
[TBL] [Abstract][Full Text] [Related]
13. Expression of matrix metalloproteinase-9 mRNA and vascular endothelial growth factor protein in gastric carcinoma and its relationship to its pathological features and prognosis.
Yang Q; Ye ZY; Zhang JX; Tao HQ; Li SG; Zhao ZS
Anat Rec (Hoboken); 2010 Dec; 293(12):2012-9. PubMed ID: 21089052
[TBL] [Abstract][Full Text] [Related]
14. Neoangiogenesis in patients with gastric carcinoma in relation to the expression of vascular endothelial growth factor and thymidine phosphorylase.
Tsujitani S; Saito H; Maeta Y; Yamaguchi K; Tatebe S; Kondo A; Kaibara N
Anticancer Res; 2004; 24(3b):1853-9. PubMed ID: 15274366
[TBL] [Abstract][Full Text] [Related]
15. High preoperative serum vascular endothelial growth factor levels predict poor clinical outcome after curative resection of gastric cancer.
Vidal O; Metges JP; Elizalde I; Valentíni M; Volant A; Molina R; Castells A; Pera M
Br J Surg; 2009 Dec; 96(12):1443-51. PubMed ID: 19918848
[TBL] [Abstract][Full Text] [Related]
16. Association between expression of transcription factor Sp1 and increased vascular endothelial growth factor expression, advanced stage, and poor survival in patients with resected gastric cancer.
Yao JC; Wang L; Wei D; Gong W; Hassan M; Wu TT; Mansfield P; Ajani J; Xie K
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4109-17. PubMed ID: 15217947
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinoma.
Kolev Y; Uetake H; Iida S; Ishikawa T; Kawano T; Sugihara K
Ann Surg Oncol; 2007 Oct; 14(10):2738-47. PubMed ID: 17687613
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
Bertolini F; Bengala C; Losi L; Pagano M; Iachetta F; Dealis C; Jovic G; Depenni R; Zironi S; Falchi AM; Luppi G; Conte PF
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1455-61. PubMed ID: 17445998
[TBL] [Abstract][Full Text] [Related]
19. The effects of VEGF and VEGFR-2 on survival in patients with gastric cancer.
Ozdemir F; Akdogan R; Aydin F; Reis A; Kavgaci H; Gul S; Akdogan E
J Exp Clin Cancer Res; 2006 Mar; 25(1):83-8. PubMed ID: 16761623
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of vascular endothelial growth factor expression in gastric cancer.
Kakeji Y; Koga T; Sumiyoshi Y; Shibahara K; Oda S; Maehara Y; Sugimachi K
J Exp Clin Cancer Res; 2002 Mar; 21(1):125-9. PubMed ID: 12071518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
